Xiaoketongbi Formula vs pregabalin for painful diabetic neuropathy: A single‐center, randomized, single‐blind, double‐dummy, and parallel controlled clinical trial

BACKGROUND: We assessed the efficacy and safety of the Xiaoketongbi Formula (XF) vs. pregabalin in patients with painful diabetic neuropathy (PDN). METHODS: Patients with PDN (n = 68) were included in a single‐center, randomized, single‐blind, double‐dummy, parallel controlled clinical trial. The pr...

Descripción completa

Detalles Bibliográficos
Autores principales: Lu, Qiyun, Chen, Benjian, Liang, Qingshun, Wu, Liyan, Luo, Lulu, Li, Anxiang, Ouyang, Wenwei, Wen, Zehuai, Liu, Yunwei, Lu, Jiayan, Liu, Yunyi, Fan, Guanjie, Liu, Zhenjie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wiley Publishing Asia Pty Ltd 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9426277/
https://www.ncbi.nlm.nih.gov/pubmed/36040201
http://dx.doi.org/10.1111/1753-0407.13306

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9426277/
https://www.ncbi.nlm.nih.gov/pubmed/36040201
http://dx.doi.org/10.1111/1753-0407.13306

Ejemplares similares